Personalized radiotherapy for lung, brain, sarcoma, or head and neck cancers
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether giving personalized radiotherapy alongside standard treatments can better control several types of cancer: small cell lung cancer, brain metastases, soft tissue sarcoma, and head and neck cancer. It aims to see if this approach helps patients live longer without their cancer growing or coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a specific type of cancer as outlined in the study (lung, brain, sarcoma, or head and neck)
- Have a good performance status (able to do daily activities)
- For some cancer types, you must not have had certain prior treatments like radiation or immunotherapy
- For some cancer types, you must be a candidate for surgery or other standard treatments
- Be willing and able to receive the study's radiation or treatment plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach to radiation therapy for central lung cancers, giving high doses in very short bursts to see if it's safe and effective. It may be an option for people whose tumors are not too large and are in a specific central location.
This trial tests combining chemotherapy (FLOT) with a new type of personalized radiation (PULSAR) before and after surgery for esophageal cancer. It aims to see if this approach is safe and effective.
This trial tests a personalized, very precise radiation treatment (called PULS-Pal) for head and neck cancer that cannot be cured with standard therapies. It aims to shrink tumors and help with symptoms while limiting side effects.
This trial tests a personalized radiation treatment called SBRT for early-stage non-small cell lung cancer that is located in the outer part of the lung and cannot be removed with surgery. The goal is to see if this approach works well for people who cannot have surgery or choose not to.
This trial tests a special type of radiation called PULSAR combined with an immunotherapy drug (anti-PD-1) in people whose cancer has spread within the abdomen or pelvis. The goal is to see if this combination can shrink tumors and help people live longer.
This trial tests a new approach combining a special type of radiation (PULSAR) with immunotherapy and chemotherapy for colorectal cancer that has spread to the liver. The goal is to see if this combination works better than standard treatments.
Hear when a new Brain Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.